| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 16.712.673 $ | 92,06 | 381.922 | |||||||
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 2.830.132 $ | 15,59 | 3.077 | |
| AbbVie Inc | AbbVie Inc | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 1.529.825 $ | 8,43 | 7.034 | |
| Novartis AG | Novartis AG | EC | 66987V109 | Long | Börsenkurs (Stufe 1) | 1.342.825 $ | 7,40 | 8.791 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 1.075.780 $ | 5,93 | 4.401 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 1.036.588 $ | 5,71 | 5.256 | |
| Bristol-Myers Squibb Co | Bristol-Myers Squibb Co | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 930.856 $ | 5,13 | 15.348 | |
| Ionis Pharmaceuticals Inc | Ionis Pharmaceuticals Inc | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 858.129 $ | 4,73 | 11.428 | |
| Amgen Inc | Amgen Inc | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 760.348 $ | 4,19 | 2.161 | |
| Alnylam Pharmaceuticals Inc | Alnylam Pharmaceuticals Inc | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 751.737 $ | 4,14 | 2.272 | |
| Alkermes PLC | Alkermes PLC | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 746.061 $ | 4,11 | 21.099 | |
| Merck & Co Inc | Merck & Co Inc | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 740.265 $ | 4,08 | 6.154 | |
| Pfizer Inc | Pfizer Inc | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 666.507 $ | 3,67 | 23.736 | |
| GSK PLC | GSK PLC | EC | 37733W204 | Long | Börsenkurs (Stufe 1) | 569.506 $ | 3,14 | 10.319 | |
| Biogen Inc | Biogen Inc | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 523.774 $ | 2,89 | 2.857 | |
| Regeneron Pharmaceuticals Inc | Regeneron Pharmaceuticals Inc | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 509.942 $ | 2,81 | 660 | |
| CRISPR Therapeutics AG | CRISPR Therapeutics AG | EC | CH0334081137 | Long | Börsenkurs (Stufe 1) | 460.049 $ | 2,53 | 9.671 | |
| Beam Therapeutics Inc | Beam Therapeutics Inc | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 209.490 $ | 1,15 | 8.791 | |
| Intellia Therapeutics Inc | Intellia Therapeutics Inc | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 169.070 $ | 0,93 | 13.188 | |
| Vanda Pharmaceuticals Inc | Vanda Pharmaceuticals Inc | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 164.016 $ | 0,90 | 23.736 | |
| Sandoz Group AG | Sandoz Group AG | EC | 799926100 | Long | Börsenkurs (Stufe 1) | 137.632 $ | 0,76 | 1.760 | |
| Galectin Therapeutics Inc | Galectin Therapeutics Inc | EC | 363225202 | Long | Börsenkurs (Stufe 1) | 137.341 $ | 0,76 | 49.226 | |
| Haleon PLC | Haleon PLC | EC | 405552100 | Long | Börsenkurs (Stufe 1) | 129.129 $ | 0,71 | 12.900 | |
| Replimune Group Inc | Replimune Group Inc | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 100.888 $ | 0,56 | 13.188 | |
| Editas Medicine Inc | Editas Medicine Inc | EC | 28106W103 | Long | Börsenkurs (Stufe 1) | 71.655 $ | 0,39 | 29.010 | |
| GE HealthCare Technologies Inc | GE HealthCare Technologies Inc | EC | 36266G107 | Long | Börsenkurs (Stufe 1) | 62.638 $ | 0,35 | 880 | |
| Bicycle Therapeutics PLC | Bicycle Therapeutics PLC | EC | 088786108 | Long | Börsenkurs (Stufe 1) | 61.192 $ | 0,34 | 13.188 | |
| Viatris Inc | Viatris Inc | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 44.205 $ | 0,24 | 3.272 | |
| Allogene Therapeutics Inc | Allogene Therapeutics Inc | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 42.900 $ | 0,24 | 17.582 | |
| Lantern Pharma Inc | Lantern Pharma Inc | EC | 51654W101 | Long | Börsenkurs (Stufe 1) | 36.131 $ | 0,20 | 26.373 | |
| Pacific Biosciences of Califor | Pacific Biosciences of California Inc | EC | 69404D108 | Long | Börsenkurs (Stufe 1) | 13.927 $ | 0,08 | 10.551 | |
| Decoy Therapeutics Inc | Decoy Therapeutics Inc | EC | 79400X602 | Long | Börsenkurs (Stufe 1) | 136 $ | 0,00 | 21 | |
| Pathos AI Inc | Pathos AI Inc | EC | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 23.992 | ||
| 16.712.673 $ | 92,06 | 381.922 |